Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy. [PDF]
Vitturi G +40 more
europepmc +1 more source
Cost-effectiveness analysis of cetuximab for the treatment of head and neck cancers in India. [PDF]
Gupta N, Dixit J, Jyani G, Prinja S.
europepmc +1 more source
Impact of Nonmedical Adalimumab Switches in a Rheumatology Patient Population. [PDF]
DelPrete S +6 more
europepmc +1 more source
Application of Actor Network Theory to Evaluate Supply and Demand Strategies Used to Encourage International Biosimilar Uptake. [PDF]
Rieger C +4 more
europepmc +1 more source
Background: Biologic therapies are central in cancer management, but the high acquisition costs limit patient access. Biosimilars, which are equivalent in quality and safety to a reference biologic, are a cost-efficient alternative.
Beddor, Ansam Nail
core +1 more source
Biosimilar Rituximab in ANCA-Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study. [PDF]
Mendel A +14 more
europepmc +1 more source
The cost-effectiveness of biosimilar denosumab in postmenopausal osteoporosis: implications of baseline fracture risk and drug price. [PDF]
Li E +5 more
europepmc +1 more source
Osteoporosis treatment with biosimilars in Malaysia and Thailand: a budget impact analysis. [PDF]
Siachalinga L +7 more
europepmc +1 more source
Biosimilar use in medical oncology in Ireland: a missed opportunity to mitigate financial toxicity? [PDF]
Burton E +7 more
europepmc +1 more source
Biosimilars in pemphigus vulgaris
Sharmila Patil +3 more
openaire +3 more sources

